08:59 AM EDT, 10/02/2024 (MT Newswires) -- Revvity ( RVTY ) said it launched Wednesday an APOE genotyping test in European countries that accept the CE mark.
The company said its Euroimmun unit's EURORealTime APOE assay enables genotyping of the APOE gene to assess a patient's risk for microbleedings in the brain and other potential side effects before starting an anti-amyloid therapy in Alzheimer's disease.
Price: 124.51, Change: -1.83, Percent Change: -1.45